National Round The Clock Hot Line
1-888-365-4458(US)  44-808-111-0143(EU)
86-108-294-5717(AS)
go to cart
1 2 3 4 5

Email Subscribe


Your Position:Home > Medical > Global Circulating Tumor Cells Market Size, Status and Forecast 2025

Global Circulating Tumor Cells Market Size, Status and Forecast 2025

Goods_sn:gz6

Publishers:QYResearch

Numbers:Share

Price:

License: single license enterprise license

Global Circulating Tumor Cells Market Size, Status and Forecast 2025

Hard Copy: 3300 USD
PDF Copy (single user): 3300 USD
Enterprise wide License: 6600 USD
Pages: 102
Tables and Figures: 117
Published Date: June 2018
Publisher: QYR Medical Care Research Center
Contact: Tel: 1-6262952442; 86-10-82945717; Email: sales@qyresearch.com

Summary

This report studies the global Circulating Tumor Cells market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Circulating Tumor Cells market by companies, region, type and end-use industry.

Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potentially guiding personalized cancer therapy.
The classification of Circulating Tumor Cells (CTCs) products includes CTC enrichment, CTC detection and CTC analysis, and the revenue proportion of CTC enrichment in 2016 is about 43.74%.
North America is the largest supplier of CTCs Products, with a revenue market share nearly 53.18% in 2016. Europe is the second largest supplier of CTCs products, enjoying revenue market share nearly 28.01% in 2016.
Growth of the global CTCs market is mainly driven by increasing prevalence of cancer globally. Increasing prevalence of various cancers such as breast cancer, prostate cancer and lung cancer is expected to drive growth of the CTCs test market over the forecast period.
FDA approvals for various non-invasive diagnostic tests to detect cancer are set to define the regulatory landscape for CTCs tests. Companies in the CTCs market space are expected to invest more on test kits and cost containment procedures to provide innovative diagnostic solutions to the oncologists and physicians for detecting metastasis.
In 2017, the global Circulating Tumor Cells market size was 1220 million US$ and it is expected to reach 3560 million US$ by the end of 2025, with a CAGR of 14.3% during 2018-2025.

This report focuses on the global top players, covered
    Menarini-Silicon Biosystems
    Qiagen(Adnagen)
    Clearbridge Biomedics
    Celsee
    Fluidigm
    ApoCell
    Greiner Bio-one GmbH
    Advanced Cell Diagnostics
    Aviva Biosciences
    Fluxion Biosciences
    Sysmex Corporation
    Epic Sciences
    Cynvenio
    CytoTrack
    Ikonisys
    Vortex BioSciences
    Gilupi
    Biocept
    ScreenCell
    ANGLE

Market segment by Regions/Countries, this report covers
    United States
    Europe
    China
    Japan
    Southeast Asia
    India

Market segment by Type, the product can be split into
    CTC Enrichment
    CTC Detection
    CTC Analysis

Market segment by Application, split into
    Breast Cancer
    Prostate Cancer
    Colorectal Cancer
    Other

The study objectives of this report are:
    To study and forecast the market size of Circulating Tumor Cells in global market.
    To analyze the global key players, SWOT analysis, value and global market share for top players.
    To define, describe and forecast the market by type, end use and region.
    To analyze and compare the market status and forecast between China and major regions, namely, United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
    To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks.
    To identify significant trends and factors driving or inhibiting the market growth.
    To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
    To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
    To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Circulating Tumor Cells are as follows:
    History Year: 2013-2017
    Base Year: 2017
    Estimated Year: 2018
    Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Circulating Tumor Cells Manufacturers
Circulating Tumor Cells Distributors/Traders/Wholesalers
Circulating Tumor Cells Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Circulating Tumor Cells market, by end-use.
Detailed analysis and profiles of additional market players.


Table of Contents

Global Circulating Tumor Cells Market Size, Status and Forecast 2025
1 Industry Overview of Circulating Tumor Cells
    1.1 Circulating Tumor Cells Market Overview
        1.1.1 Circulating Tumor Cells Product Scope
        1.1.2 Market Status and Outlook
    1.2 Global Circulating Tumor Cells Market Size and Analysis by Regions (2013-2018)
        1.2.1 United States
        1.2.2 Europe
        1.2.3 China
        1.2.4 Japan
        1.2.5 Southeast Asia
        1.2.6 India
    1.3 Circulating Tumor Cells Market by Type
        1.3.1 CTC Enrichment
        1.3.2 CTC Detection
        1.3.3 CTC Analysis
    1.4 Circulating Tumor Cells Market by End Users/Application
        1.4.1 Breast Cancer
        1.4.2 Prostate Cancer
        1.4.3 Colorectal Cancer
        1.4.4 Other

2 Global Circulating Tumor Cells Competition Analysis by Players
    2.1 Circulating Tumor Cells Market Size (Value) by Players (2013-2018)
    2.2 Competitive Status and Trend
        2.2.1 Market Concentration Rate
        2.2.2 Product/Service Differences
        2.2.3 New Entrants
        2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
    3.1 Menarini-Silicon Biosystems
        3.1.1 Company Profile
        3.1.2 Main Business/Business Overview
        3.1.3 Products, Services and Solutions
        3.1.4 Circulating Tumor Cells Revenue (Million USD) (2013-2018)
    3.2 Qiagen(Adnagen)
        3.2.1 Company Profile
        3.2.2 Main Business/Business Overview
        3.2.3 Products, Services and Solutions
        3.2.4 Circulating Tumor Cells Revenue (Million USD) (2013-2018)
    3.3 Clearbridge Biomedics
        3.3.1 Company Profile
        3.3.2 Main Business/Business Overview
        3.3.3 Products, Services and Solutions
        3.3.4 Circulating Tumor Cells Revenue (Million USD) (2013-2018)
    3.4 Celsee
        3.4.1 Company Profile
        3.4.2 Main Business/Business Overview
        3.4.3 Products, Services and Solutions
        3.4.4 Circulating Tumor Cells Revenue (Million USD) (2013-2018)
    3.5 Fluidigm
        3.5.1 Company Profile
        3.5.2 Main Business/Business Overview
        3.5.3 Products, Services and Solutions
        3.5.4 Circulating Tumor Cells Revenue (Million USD) (2013-2018)
    3.6 ApoCell
        3.6.1 Company Profile
        3.6.2 Main Business/Business Overview
        3.6.3 Products, Services and Solutions
        3.6.4 Circulating Tumor Cells Revenue (Million USD) (2013-2018)
    3.7 Greiner Bio-one GmbH
        3.7.1 Company Profile
        3.7.2 Main Business/Business Overview
        3.7.3 Products, Services and Solutions
        3.7.4 Circulating Tumor Cells Revenue (Million USD) (2013-2018)
    3.8 Advanced Cell Diagnostics
        3.8.1 Company Profile
        3.8.2 Main Business/Business Overview
        3.8.3 Products, Services and Solutions
        3.8.4 Circulating Tumor Cells Revenue (Million USD) (2013-2018)
    3.9 Aviva Biosciences
        3.9.1 Company Profile
        3.9.2 Main Business/Business Overview
        3.9.3 Products, Services and Solutions
        3.9.4 Circulating Tumor Cells Revenue (Million USD) (2013-2018)
    3.10 Fluxion Biosciences
        3.10.1 Company Profile
        3.10.2 Main Business/Business Overview
        3.10.3 Products, Services and Solutions
        3.10.4 Circulating Tumor Cells Revenue (Million USD) (2013-2018)
    3.11 Sysmex Corporation
    3.12 Epic Sciences
    3.13 Cynvenio
    3.14 CytoTrack
    3.15 Ikonisys
    3.16 Vortex BioSciences
    3.17 Gilupi
    3.18 Biocept
    3.19 ScreenCell
    3.20 ANGLE

4 Global Circulating Tumor Cells Market Size by Type and Application (2013-2018)
    4.1 Global Circulating Tumor Cells Market Size by Type (2013-2018)
    4.2 Global Circulating Tumor Cells Market Size by Application (2013-2018)
    4.3 Potential Application of Circulating Tumor Cells in Future
    4.4 Top Consumer/End Users of Circulating Tumor Cells

5 United States Circulating Tumor Cells Development Status and Outlook
    5.1 United States Circulating Tumor Cells Market Size (2013-2018)
    5.2 United States Circulating Tumor Cells Market Size and Market Share by Players (2013-2018)
    5.3 United States Circulating Tumor Cells Market Size by Application (2013-2018)

6 Europe Circulating Tumor Cells Development Status and Outlook
    6.1 Europe Circulating Tumor Cells Market Size (2013-2018)
    6.2 Europe Circulating Tumor Cells Market Size and Market Share by Players (2013-2018)
    6.3 Europe Circulating Tumor Cells Market Size by Application (2013-2018)

7 China Circulating Tumor Cells Development Status and Outlook
    7.1 China Circulating Tumor Cells Market Size (2013-2018)
    7.2 China Circulating Tumor Cells Market Size and Market Share by Players (2013-2018)
    7.3 China Circulating Tumor Cells Market Size by Application (2013-2018)

8 Japan Circulating Tumor Cells Development Status and Outlook
    8.1 Japan Circulating Tumor Cells Market Size (2013-2018)
    8.2 Japan Circulating Tumor Cells Market Size and Market Share by Players (2013-2018)
    8.3 Japan Circulating Tumor Cells Market Size by Application (2013-2018)

9 Southeast Asia Circulating Tumor Cells Development Status and Outlook
    9.1 Southeast Asia Circulating Tumor Cells Market Size (2013-2018)
    9.2 Southeast Asia Circulating Tumor Cells Market Size and Market Share by Players (2013-2018)
    9.3 Southeast Asia Circulating Tumor Cells Market Size by Application (2013-2018)

10 India Circulating Tumor Cells Development Status and Outlook
    10.1 India Circulating Tumor Cells Market Size (2013-2018)
    10.2 India Circulating Tumor Cells Market Size and Market Share by Players (2013-2018)
    10.3 India Circulating Tumor Cells Market Size by Application (2013-2018)

11 Market Forecast by Regions, Type and Application (2018-2025)
    11.1 Global Circulating Tumor Cells Market Size (Value) by Regions (2018-2025)
        11.1.1 United States Circulating Tumor Cells Revenue and Growth Rate (2018-2025)
        11.1.2 Europe Circulating Tumor Cells Revenue and Growth Rate (2018-2025)
        11.1.3 China Circulating Tumor Cells Revenue and Growth Rate (2018-2025)
        11.1.4 Japan Circulating Tumor Cells Revenue and Growth Rate (2018-2025)
        11.1.5 Southeast Asia Circulating Tumor Cells Revenue and Growth Rate (2018-2025)
        11.1.6 India Circulating Tumor Cells Revenue and Growth Rate (2018-2025)
    11.2 Global Circulating Tumor Cells Market Size (Value) by Type (2018-2025)
    11.3 Global Circulating Tumor Cells Market Size by Application (2018-2025)

12 Circulating Tumor Cells Market Dynamics
    12.1 Circulating Tumor Cells Market Opportunities
    12.2 Circulating Tumor Cells Challenge and Risk
        12.2.1 Competition from Opponents
        12.2.2 Downside Risks of Economy
    12.3 Circulating Tumor Cells Market Constraints and Threat
        12.3.1 Threat from Substitute
        12.3.2 Government Policy
        12.3.3 Technology Risks
    12.4 Circulating Tumor Cells Market Driving Force
        12.4.1 Growing Demand from Emerging Markets
        12.4.2 Potential Application

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs Trend/Customer Preference
    13.3 External Environmental Change
        13.3.1 Economic Fluctuations
        13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
    Methodology
    Analyst Introduction
    Data Source


List of Tables and Figures

    Figure Global Circulating Tumor Cells Market Size (Million USD) Status and Outlook (2013-2018)
    Table Global Circulating Tumor Cells Revenue (Million USD) Comparison by Regions (2013-2018)
    Figure Global Circulating Tumor Cells Market Share by Regions (2013-2018)
    Figure United States Circulating Tumor Cells Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Figure Europe Circulating Tumor Cells Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Figure China Circulating Tumor Cells Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Figure Japan Circulating Tumor Cells Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Figure Southeast Asia Circulating Tumor Cells Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Figure India Circulating Tumor Cells Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Table Global Circulating Tumor Cells Revenue (Million USD) and Growth Rate (%) Comparison by Product (2013-2018)
    Figure Global Circulating Tumor Cells Revenue Market Share by Type in 2017
    Figure CTC Enrichment Market Size (Million USD) and Growth Rate (2013-2018)
    Figure CTC Detection Market Size (Million USD) and Growth Rate (2013-2018)
    Figure CTC Analysis Market Size (Million USD) and Growth Rate (2013-2018)
    Figure Global Circulating Tumor Cells Market Share by Application in 2017
    Figure Circulating Tumor Cells Market Size (Million USD) and Growth Rate in Breast Cancer (2013-2018)
    Figure Circulating Tumor Cells Market Size (Million USD) and Growth Rate in Prostate Cancer (2013-2018)
    Figure Circulating Tumor Cells Market Size (Million USD) and Growth Rate in Colorectal Cancer (2013-2018)
    Figure Circulating Tumor Cells Market Size (Million USD) and Growth Rate in Other (2013-2018)
    Table Circulating Tumor Cells Market Size (Million USD) by Players (2013-2018)
    Figure Circulating Tumor Cells Market Size Share by Players in 2013
    Figure Circulating Tumor Cells Market Size Share by Players in 2017
    Table Menarini-Silicon Biosystems Basic Information List
    Table Circulating Tumor Cells Business Revenue (Million USD) of Menarini-Silicon Biosystems (2013-2018)
    Figure Menarini-Silicon Biosystems Circulating Tumor Cells Business Revenue Market Share (2013-2018)
    Table Qiagen(Adnagen) Basic Information List
    Table Circulating Tumor Cells Business Revenue (Million USD) of Qiagen(Adnagen) (2013-2018)
    Figure Qiagen(Adnagen) Circulating Tumor Cells Business Revenue Market Share (2013-2018)
    Table Clearbridge Biomedics Basic Information List
    Table Circulating Tumor Cells Business Revenue (Million USD) of Clearbridge Biomedics (2013-2018)
    Figure Clearbridge Biomedics Circulating Tumor Cells Business Revenue Market Share (2013-2018)
    Table Celsee Basic Information List
    Table Circulating Tumor Cells Business Revenue (Million USD) of Celsee (2013-2018)
    Figure Celsee Circulating Tumor Cells Business Revenue Market Share (2013-2018)
    Table Fluidigm Basic Information List
    Table Circulating Tumor Cells Business Revenue (Million USD) of Fluidigm (2013-2018)
    Figure Fluidigm Circulating Tumor Cells Business Revenue Market Share (2013-2018)
    Table ApoCell Basic Information List
    Table Circulating Tumor Cells Business Revenue (Million USD) of ApoCell (2013-2018)
    Figure ApoCell Circulating Tumor Cells Business Revenue Market Share (2013-2018)
    Table Greiner Bio-one GmbH Basic Information List
    Table Circulating Tumor Cells Business Revenue (Million USD) of Greiner Bio-one GmbH (2013-2018)
    Figure Greiner Bio-one GmbH Circulating Tumor Cells Business Revenue Market Share (2013-2018)
    Table Advanced Cell Diagnostics Basic Information List
    Table Circulating Tumor Cells Business Revenue (Million USD) of Advanced Cell Diagnostics (2013-2018)
    Figure Advanced Cell Diagnostics Circulating Tumor Cells Business Revenue Market Share (2013-2018)
    Table Aviva Biosciences Basic Information List
    Table Circulating Tumor Cells Business Revenue (Million USD) of Aviva Biosciences (2013-2018)
    Figure Aviva Biosciences Circulating Tumor Cells Business Revenue Market Share (2013-2018)
    Table Fluxion Biosciences Basic Information List
    Table Circulating Tumor Cells Business Revenue (Million USD) of Fluxion Biosciences (2013-2018)
    Figure Fluxion Biosciences Circulating Tumor Cells Business Revenue Market Share (2013-2018)
    Table Sysmex Corporation Basic Information List
    Table Circulating Tumor Cells Business Revenue (Million USD) of Sysmex Corporation (2013-2018)
    Figure Sysmex Corporation Circulating Tumor Cells Business Revenue Market Share (2013-2018)
    Table Epic Sciences Basic Information List
    Table Circulating Tumor Cells Business Revenue (Million USD) of Epic Sciences (2013-2018)
    Figure Epic Sciences Circulating Tumor Cells Business Revenue Market Share (2013-2018)
    Table Cynvenio Basic Information List
    Table CytoTrack Basic Information List
    Table Ikonisys Basic Information List
    Table Vortex BioSciences Basic Information List
    Table Gilupi Basic Information List
    Table Biocept Basic Information List
    Table ScreenCell Basic Information List
    Table ANGLE Basic Information List
    Table Global Circulating Tumor Cells Market Size (Million USD) by Product (2013-2018)
    Figure Global Circulating Tumor Cells Revenue Market Share (%) by Product (2013-2018)
    Figure Global Circulating Tumor Cells Market Share by Product in 2017
    Table Global Circulating Tumor Cells Market Size by Application (2013-2018)
    Figure Global Circulating Tumor Cells Revenue Market Share (%) by Application in 2017
    Table Top Consumer/End Users of Circulating Tumor Cells
    Figure United States Circulating Tumor Cells Market Size (Million USD) and Growth Rate (2013-2018)
    Table United States Circulating Tumor Cells Market Size (Million USD) by Players (2013-2018)
    Figure United States Circulating Tumor Cells Market Size Share by Players in 2013
    Figure United States Circulating Tumor Cells Market Size Share by Players in 2017
    Table United States Circulating Tumor Cells Market Size by Application (2013-2018)
    Figure United States Circulating Tumor Cells Revenue Market Share (%) by Application (2013-2018)
    Figure United States Circulating Tumor Cells Market Size Share by Application in 2017
    Figure Europe Circulating Tumor Cells Market Size (Million USD) and Growth Rate (2013-2018)
    Table Europe Circulating Tumor Cells Market Size (Million USD) by Players (2013-2018)
    Figure Europe Circulating Tumor Cells Market Size Share by Players in 2013
    Figure Europe Circulating Tumor Cells Market Size Share by Players in 2017
    Table Europe Circulating Tumor Cells Market Size by Application (2013-2018)
    Figure Europe Circulating Tumor Cells Revenue Market Share (%) by Application (2013-2018)
    Figure Europe Circulating Tumor Cells Market Size Share by Application in 2017
    Figure China Circulating Tumor Cells Market Size (Million USD) and Growth Rate (2013-2018)
    Table China Circulating Tumor Cells Market Size (Million USD) by Players (2013-2018)
    Figure China Circulating Tumor Cells Market Size Share by Players in 2013
    Figure China Circulating Tumor Cells Market Size Share by Players in 2017
    Table China Circulating Tumor Cells Market Size by Application (2013-2018)
    Figure China Circulating Tumor Cells Revenue Market Share (%) by Application (2013-2018)
    Figure China Circulating Tumor Cells Market Size Share by Application in 2017
    Figure Japan Circulating Tumor Cells Market Size (Million USD) and Growth Rate (2013-2018)
    Table Japan Circulating Tumor Cells Market Size (Million USD) by Players (2013-2018)
    Figure Japan Circulating Tumor Cells Market Size Share by Players in 2013
    Figure Japan Circulating Tumor Cells Market Size Share by Players in 2017
    Table Japan Circulating Tumor Cells Market Size by Application (2013-2018)
    Figure Japan Circulating Tumor Cells Revenue Market Share (%) by Application (2013-2018)
    Figure Japan Circulating Tumor Cells Market Size Share by Application in 2017
    Figure Southeast Asia Circulating Tumor Cells Market Size (Million USD) and Growth Rate (2013-2018)
    Table Southeast Asia Circulating Tumor Cells Market Size (Million USD) by Players (2013-2018)
    Figure Southeast Asia Circulating Tumor Cells Market Size Share by Players in 2013
    Figure Southeast Asia Circulating Tumor Cells Market Size Share by Players in 2017
    Table Southeast Asia Circulating Tumor Cells Market Size by Application (2013-2018)
    Figure Southeast Asia Circulating Tumor Cells Revenue Market Share (%) by Application (2013-2018)
    Figure Southeast Asia Circulating Tumor Cells Market Size Share by Application in 2017
    Figure India Circulating Tumor Cells Market Size (Million USD) and Growth Rate (2013-2018)
    Table India Circulating Tumor Cells Market Size (Million USD) by Players (2013-2018)
    Figure India Circulating Tumor Cells Market Size Share by Players in 2013
    Figure India Circulating Tumor Cells Market Size Share by Players in 2017
    Table India Circulating Tumor Cells Market Size by Application (2013-2018)
    Figure India Circulating Tumor Cells Revenue Market Share (%) by Application (2013-2018)
    Figure India Circulating Tumor Cells Market Size Share by Application in 2017
    Figure Global Circulating Tumor Cells Market Size and Growth Rate (2018-2025)
    Table Global Circulating Tumor Cells Market Size (Million USD) by Regions (2018-2025)
    Figure Global Circulating Tumor Cells Market Size Share (2018-2025)
    Figure Global Circulating Tumor Cells Market Size Share by Regions in 2025
    Figure United States Circulating Tumor Cells Revenue (Million USD) and Growth Rate (2018-2025)
    Figure Europe Circulating Tumor Cells Revenue (Million USD) and Growth Rate (2018-2025)
    Figure China Circulating Tumor Cells Revenue (Million USD) and Growth Rate (2018-2025)
    Figure Japan Circulating Tumor Cells Revenue (Million USD) and Growth Rate (2018-2025)
    Figure Southeast Asia Circulating Tumor Cells Revenue (Million USD) and Growth Rate (2018-2025)
    Figure India Circulating Tumor Cells Revenue (Million USD) and Growth Rate (2018-2025)
    Table Global Circulating Tumor Cells Market Size (Million USD) by Type (2018-2025)
    Figure Global Circulating Tumor Cells Market Size Share by Type in 2018
    Figure Global Circulating Tumor Cells Market Size Share by Type in 2025
    Table Global Circulating Tumor Cells Market Size (Million USD) by Application (2018-2025)
    Figure Global Circulating Tumor Cells Market Size (Million USD) by Application in 2018

Request sample If you need any reports sample, just let us know.